Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.22.

  • Maravai Lifesciences Holdings' Asset Utilization Ratio rose 838.61% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 838.61%. This contributed to the annual value of 0.21 for FY2024, which is 3549.32% up from last year.
  • Maravai Lifesciences Holdings' Asset Utilization Ratio amounted to 0.22 in Q3 2025, which was up 838.61% from 0.24 recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Asset Utilization Ratio high stood at 0.45 for Q1 2022, and its period low was 0.15 during Q4 2023.
  • In the last 5 years, Maravai Lifesciences Holdings' Asset Utilization Ratio had a median value of 0.25 in 2025 and averaged 0.29.
  • In the last 5 years, Maravai Lifesciences Holdings' Asset Utilization Ratio skyrocketed by 5542.79% in 2022 and then crashed by 6051.26% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Asset Utilization Ratio (Quarter) stood at 0.42 in 2021, then fell by 7.03% to 0.39 in 2022, then tumbled by 60.51% to 0.15 in 2023, then skyrocketed by 47.31% to 0.23 in 2024, then dropped by 2.78% to 0.22 in 2025.
  • Its last three reported values are 0.22 in Q3 2025, 0.24 for Q2 2025, and 0.25 during Q1 2025.